Rotor-based image-guided therapy of glioblastoma.

J Control Release

Allan H. Conney Laboratory for Anticancer Research, School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China. Electronic address:

Published: April 2024

Glioblastoma (GBM), deep in the brain, is more challenging to diagnose and treat than other tumors. Such challenges have blocked the development of high-impact therapeutic approaches that combine reliable diagnosis with targeted therapy. Herein, effective cyanine dyes (IRLy) with the near-infrared two region (NIR-II) adsorption and aggregation-induced emission (AIE) have been developed via an "extended conjugation & molecular rotor" strategy for multimodal imaging and phototherapy of deep orthotopic GBM. IRLy was synthesized successfully through a rational molecular rotor modification with stronger penetration, higher signal-to-noise ratio, and a high photothermal conversion efficiency (PCE) up to ∼60%, which can achieve efficient NIR-II photo-response. The multifunctional nanoparticles (Tf-IRLy NPs) were further fabricated to cross the blood-brain barrier (BBB) introducing transferrin (Tf) as a targeting ligand. Tf-IRLy NPs showed high biosafety and good tumor enrichment for GBM in vitro and in vivo, and thus enabled accurate, efficient, and less invasive NIR-II multimodal imaging and photothermal therapy. This versatile Tf-IRLy nanosystem can provide a reference for the efficient, precise and low-invasive multi-synergistic brain targeted photo-theranostics. In addition, the "extended conjugation & molecular rotor" strategy can be used to guide the design of other photothermal agents.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jconrel.2024.03.020DOI Listing

Publication Analysis

Top Keywords

"extended conjugation
8
conjugation molecular
8
molecular rotor"
8
rotor" strategy
8
multimodal imaging
8
tf-irly nps
8
rotor-based image-guided
4
image-guided therapy
4
therapy glioblastoma
4
glioblastoma glioblastoma
4

Similar Publications

Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy.

Int J Biol Macromol

January 2025

Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, School of Pharmacy, Fudan University, Shanghai 201203, China.

Acute myeloid leukemia (AML) is a severe blood cancer with an urgent need for novel therapies for refractory or relapsed patients. Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), an immune suppressive receptor expressed on immune cells and AML blasts but minimally on hematopoietic stem cells (HSCs), represents a potential therapeutic target. But there has been limited research on therapies targeting LAIR1 for AML and no published reports on LAIR1 antibody-drug conjugate (ADC).

View Article and Find Full Text PDF

Spatiotemporal Spectroscopy of Fast Excited-State Diffusion in 2D Covalent Organic Framework Thin Films.

J Am Chem Soc

January 2025

Department of Chemistry and Center for NanoScience (CeNS), University of Munich (LMU), Butenandtstraße 5-13, Munich 81377, Germany.

Covalent organic frameworks (COFs), crystalline and porous conjugated structures, are of great interest for sustainable energy applications. Organic building blocks in COFs with suitable electronic properties can feature strong optical absorption, whereas the extended crystalline network can establish a band structure enabling long-range coherent transport. This peculiar combination of both molecular and solid-state materials properties makes COFs an interesting platform to study and ultimately utilize photoexcited charge carrier diffusion.

View Article and Find Full Text PDF
Article Synopsis
  • PVDF is a promising material for solid polymer electrolytes because of its good thermal stability and wide electrochemical range, but it faces issues with poor ionic conductivity due to the formation of a harmful alkaline layer on garnet fillers.
  • LiOH on the surface of these fillers contributes to the breakdown of PVDF chains, leading to unwanted chemical bonds; this can be mitigated by treating the fillers with acetic acid to create alkali-free garnets.
  • The modified PVDF electrolyte shows significantly improved ionic conductivity and a wider electrochemical window, resulting in better performance for solid-state lithium batteries, evidenced by higher discharge capacity and cycle stability.
View Article and Find Full Text PDF

Design and Regulation of Anthraquinone's Electrochemical Properties in Aqueous Zinc-Ion Batteries via Benzothiadiazole and Its Dinitro Derivatives.

ACS Appl Mater Interfaces

January 2025

Key Laboratory of Functional Inorganic Material Chemistry, Ministry of Education, and Department of Macromolecular Science and Engineering, School of Chemistry and Chemical Engineering, Heilongjiang University, Harbin 150080, P. R. China.

Article Synopsis
  • Organic cathode materials are promising for aqueous zinc-ion batteries (AZIBs) due to their low cost and tunable properties, with benzothiadiazoles showing potential for effective electron acceptance.
  • A new polymer, PBDQ-N, was designed by adding nitro groups to enhance electron delocalization and increase active sites, resulting in better zinc-ion insertion/extraction.
  • PBDQ-N exhibited exceptional electrochemical performance with a specific capacity of 446.2 mAh/g and a cycle life of over 20,000 cycles, highlighting the importance of molecular design in optimizing battery materials.
View Article and Find Full Text PDF

Tertiary amine modification enables triterpene nanoparticles to target the mitochondria and treat glioblastoma via pyroptosis induction.

Biomaterials

December 2024

Department of Neurosurgery, Yale University, New Haven, CT, 06511, USA; Department of Biomedical Engineering, Yale University, New Haven, CT, 06510, USA. Electronic address:

Glioblastoma (GBM), the most common primary brain tumor, lacks effective treatments. Emerging evidence suggests mitochondria as a promising therapeutic target, albeit successfully targeting represents a major challenge. Recently, we discovered a group of triterpenes that can self-assemble into nanoparticles (NPs) for cancer treatment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!